Our study presents evidence for the effects of MSCs on SH-SY5Y neuroblastoma cells by investigating Annexin-V and Caspase-3 assay, telomere length, telomerase, and β-Galactosidase activity assessment through BAX and BCL2 signaling pathways. The gene discussed is ANXA5; the disease is neuroblastoma.